The Origin of Proinflammatory Cytokines in Patients with Idiopathic Dilated Cardiomyopathy

Journal of Korean Medical Science

Volumn 18, Issue 6, 2003, Pages 791-796

  Chang, Hyuk Jae ^a   Chung, Jaehoon ^a   Choi, Byoung Joo ^a   Choi, Tae Young ^a   Choi, So Yeon ^a   Yoon, Myeong Ho ^a   Hwang, Gyo Seung ^a   Shin, Joon Han ^a   Tahk, Seung Jea ^a   Choi, Byung Il William ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Congestive; Cytokines; Heart Failure; Myocardial Diseases

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTERY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY SINUS; CYTOKINE RELEASE; DISEASE EXACERBATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HOSPITAL ADMISSION; HUMAN; INFERIOR CAVA VEIN; INFLAMMATION; MALE; MEASUREMENT; PATIENT; PROTEIN BLOOD LEVEL;

EID: 0346433916     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.6.791     Document Type: Article

References (29)

1. Paulus WJ. How are cytokines activated in heart failure ? Eur J Heart Fail 1999; 1: 309-12.
2. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77: 723-7.
3. Kubota T, Miyagishima M, Alvarez RJ, Kormos R, Rosenblum WD, Demetris AJ, Semigran MJ, Dec GW, Holubkov R, McTiernan CF, Mann DL, Feldman AM, McNamara DM. Expression of proinflammatory cytokines in the failing human heart: Comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000; 19: 819-24.
4. Bozkurt B, Kribbs S, Clubb FJ Jr, Michael LH, Didenko W, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-91.
5. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β, modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995; 96: 1093-9.
6. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ Res 1997; 81: 627-35.
7. Feldman AM, Kadokami T, Higuichi Y, Ramani R, McTiernan CF. The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials. Med Clin North Am 2003; 87: 419-40.
8. Anker SD, Egerer KR, Volk H-D, Kox WJ, Poole-Wilson PA, Coats AJS. Elevated soluble CD 14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997; 79: 1426-30.
9. Torre-Amione G, Kapadia S, Benedict CR, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies on Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6.
10. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res 1997; 81: 187-95.
11. Adams V, Jiang H, Yu J, Mobius-Winkler S, Fiehn E, Linke A, Weigl C, Schuler G, Hambrecht R. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 1999; 33: 959-65.
12. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-33.
13. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
14. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanism in heart failure: the cytokine hypothesis. J Card Fail 1996; 2: 243-9.
15. Deliargyris EN, Raymond RJ, Theoharides TC, Boucher WS, Tate DA, Dehmer GJ. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 2000; 86: 913-8.
16. Petretta M, Condorelli GL, Spinelli L, Scopacasa F, De Caterina M, Leosco D, Vicario ML, Bonaduce D. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J 2000; 140: E28.
17. Old LJ. Tumor necrosis factor (TNF). Science 1985; 230: 630-2.
18. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-52.
19. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-11.
20. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997; 95: 778-81.
21. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323-9.
22. Saraste A, Voipio-Pulkki LM, Heikkila P, Laine P, Nieminen MS, Pulkki K. Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients with increased cardiomyocyte apoptosis. Clin Chim Acta 2002; 320: 65-7.
23. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.
24. Wei CC, Meng QC, Palmer R, Hageman GR, Durand J, Bradley WE, Farrell DM, Hankes GH, Oparil S, Dell'Italia LJ. Evidence for angiotensin-converting enzyme-and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation 1999; 99: 2583-9.
25. Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X, Heras M,'Sanz G. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 2000; 19: 419-25.
26. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998; 31: 391-8.
27. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748-55.
28. Feldman AM, Combes A, Wagner D , Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000; 35: 537-44.
29. Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W, Stanek B. Circulating tumor necrosis factor-alpha. Levels in chronic heart failure: relation to its soluble receptor II, interleukin-6 and neurohumoral variables. J Heart Lung Transplant 1998; 17: 356-62.